chevron_leftBack
As of 13 June 2026, Harbor Diversified, Inc. has a market cap of $93.49M USD, ranking #26022 globally and #3988 in the United States.
It ranks #2330 in the Healthcare sector, and #840 in the Drug Manufacturers - General industry.
Key Stats
Market Cap
$93.49MUSD
Enterprise Value
-$10.04MUSD
Revenue (TTM)
$202.38MUSD
EBITDA (TTM)
$1.85MUSD
Net Income (TTM)
-$18.27MUSD
EBITDA Margin
0.9%
Profit Margin
-8.5%
PS Ratio
0.5
PB Ratio
0.6
Company Profile
Country (HQ)
Sector
Healthcare
Industry
Drug Manufacturers - General
CEO
Christine Deister
open_in_new
Employees
944
Founded
1992
warningChart data may be delayed
| 1d | 1w | 1m | 3m | 6m | 1y |
|---|---|---|---|---|---|
| 3.2% | 1.3% | 6.7% | 6.7% | 62% | 300% |
News
Loading...
Markets
| Exchange | Ticker | Price |
|---|---|---|
|
HRBR
Harbor Diversified Inc
ISIN: US41150R1023
Shares Out.:
Shares Outstanding:
58.43M1
Shares Float:
38.43M2
TV:
TradingView:
SA:
Stock Analysis:
YF:
Yahoo Finance:
GF:
Google Finance:
BA:
Barron's:
MS:
Morningstar:
|
1.60 USD |
1Market cap is calculated using shares outstanding.
2Float shares are publicly tradable shares, excluding insider-held stock.
About Harbor Diversified, Inc.
Harbor Diversified, Inc. provides regional air services in the United States. The company leases flight equipment; and provides flight equipment financing. As of December 31, 2023, it owned and operated a fleet of 63 regional jets. Harbor Diversified, Inc. is headquartered in Appleton, Wisconsin.
Similar Companies
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
NYSE: LLY
|
$761.68B
815K%
|
38.1
|
|
NYSE: JNJ
|
$547.28B
585K%
|
26.4
|
|
NYSE: ABBV
|
$360.63B
386K%
|
97.4
|
|
NYSE: MRK
|
$274.03B
293K%
|
15.1
|
|
NYSE: PFE
|
$149.38B
160K%
|
19.5
|
|
NYSE: BMY
|
$117.58B
126K%
|
16.8
|
| Name |
Market Cap (USD)
diff.
|
PE | Country |
|---|---|---|---|
SIX: RO
|
$321.52B
344K%
256.25B CHF
|
19.9
|
|
LSE: AZN
|
$288.84B
309K%
215.59B GBP
|
27.6
|
|
SIX: NOVN
|
$274.65B
294K%
218.9B CHF
|
20.5
|
|
CPH: NOVO-B
|
$181.82B
194K%
1.18T DKK
|
11.5
|
|
EPA: SAN
|
$110.1B
118K%
95.26B EUR
|
19.9
|
|
LSE: GSK
|
$108.46B
116K%
80.96B GBP
|
14.6
|
chevron_leftBack